Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Funding and backers

Total raised
$160M
2 rounds on record
Latest round
$120M
Series B · Apr 2021 · 5 yr ago
Team
355
US Form 5500 (plan participants) · Dec 2024
Hiring now
13
+5 posted in 30 days
Backers
4
Xontogeny, RA Capital Management
The money's age
Long since its last round
66 months since the last round · and hiring
Momentum
15/100
hiring for its size
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 28, 2021 Raised a round Series B $120M Jul 20, 2020 Raised a round Venture round $40M · SEC Form D 2020 Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Series B Apr 2021 $120M — businesswire.com
Venture round Jul 2020 $40M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Forge Biologics Holdings, LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Timothy MillerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Genezen21 roles
Viral vector CDMO delivering AAV, lentiviral and retroviral vector manufacturing for cell and gene therapy developers from preclinical to…
ViralgenFounded 2017
At Viralgen, we're proud to be known for just one thing: Being a world leader in AAV-based gene therapy manufacturing.. We're all in on…
August Bioservices201-500 employees · 26 roles
August Bioservices is a sterile injectable CDMO providing contract manufacturing for pharmaceutical companies.
GeneVentiv TherapeuticsVenture round $1.4M · 4 yr ago · Founded 2020 · 11-50 employees
GeneVentiv Therapeutics — advancing gene therapy approaches.
Siren BiotechnologyVenture round $19.6M · 2 yr ago · Founded 2020 · 11-50 employees
SAN FRANCISCO, CA [Jan. 28, 2026] – Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the…
ElevateBioVenture round $525M · 5 yr ago · Founded 2017 · 201-500 employees · 13 roles
ElevateBio is a technology-driven company that helps partners realize the potential of their cell and gene therapies from design to…

Visa sponsorship

#3,811 of 8,228 sponsors
2 ▼ 71%
H-1B filings in 12 months
$108k
Median offered salary
13
Open roles in United States
Who they sponsor
Industrial engineers
1
Other biological scientists
1
The salary offered for each occupationVisa pass · 90 credits
In the register as Forge Biologics Inc., Grove City, OH
Other sponsors in the same field
US Department of Labor · latest filing Jun 23, 2026 · Visa details by country

Overview

Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors4
XontogenyVia a fund
27 portfolio companies: Zucara, TORL BioTherapeutics LLC, VivoSense and 24 more
Drive CapitalVia a fund
80 portfolio companies: Immuta, Greenlight, Algolux and 77 more
Aisling CapitalVia a fund
117 portfolio companies: CoolSculpting, Zosanopharma, Shofsky and 114 more
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more
Show all 4

News

Blog 4 months ago
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
Forge's development and manufacturing services support RV-001, Restore Vision's gene therapy for patients with retinitis pigmentosa, in Phase 1/2 clinical evaluation in Japan TOKYO, JAPAN and COLUMBUS, OH - July 21, 2026 - Restore Vision, Inc. ("Restore V
Read more
Report
Blog 5 months ago
Skylark Bio and Forge Biologics Announce Strategic AAV Development and cGMP Manufacturing Partnership Supporting Skylark's Clinical Development
Skylark Bio is leveraging Forge's AAV FUEL platform technologies and cGMP manufacturing services to advance its gene therapy for patients with genetic hearing loss CAMBRIDGE, MA and COLUMBUS, OH - June 16, 2026 - Skylark Bio ("Skylark"), a clinical-stage
Read more
Report
Blog 6 months ago
Forge Biologics Announces Seven Presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Oral and poster presentations highlight data from Forge's FUEL AAV manufacturing platform and advancements in process characterization and late-phase manufacturing to support the growing number of gene therapy programs advancing toward commercialization C
Read more
Report
Blog 6 months ago
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
Forge's FUEL platform and manufacturing services support the production of AAV for EPI-321, Epicrispr's investigational gene therapy for FSHD Material manufactured at Forge for Epicrispr is being used in a clinical trial across the U.S., New Zealand, and
Read more
Report
Blog 7 months ago
Forge Biologics Among Select Global CDMOs to Earn My Green Lab Certification Across All Laboratories and cGMP Suites
COLUMBUS, Ohio - April 22, 2026 - Forge Biologics, ("Forge"), a leading manufacturer of gene therapies and member of the Ajinomoto Bio-Pharma Services group, today announced it has achieved My Green Lab Certification, the global gold standard for laborato
Read more
Report
Blog 8 months ago
The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria
Partnership marks a critical step toward clinical development of an AAV gene therapy using a base editing approach designed to target theapproach designed to target the genetic cause of Hutchinson-Gilford Progeria Syndrome Forge Biologics will provide pro
Read more
Report
Blog 10 months ago
Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
Forge's FUEL platform and cGMP manufacturing services support the production of AAV for Ascidian's ACDN-01, the most advanced genetic therapy targeting the underlying cause of Stargardt disease Collaboration secures clinical supply needed to advance ACDN-
Read more
Report
Blog 1 year ago
Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
Avista will leverage Forge's FUEL platform to manufacture AAV for AVST-101, Avista's lead gene therapy to treat patients with X-linked retinoschisis (XLRS) PITTSBURGH, Pennsylvania and COLUMBUS, Ohio - August 13, 2025 - Avista Therapeutics ("Avista"), a p
Read more
Report
Blog 1 year ago
Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases
Fractyl Health will leverage Forge's FUEL platform to manufacture AAV for Rejuva, Fractyl's pancreatic gene therapy platform for patients with obesity and type 2 diabetes COLUMBUS, Ohio - May 14, 2025 - Forge Biologics ("Forge"), a leading manufacturer of
Read more
Report
Blog 1 year ago
Forge Biologics Announces Eight Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Oral and poster presentations will highlight data demonstrating the enhanced productivity, recovery, and consistent quality of Forge's FUEL AAV manufacturing platform, addressing the industry's need for more efficient manufacturing COLUMBUS, Ohio - May 6,
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Forge Biologics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
15
Postings analysed
15
Stack modernity
57/100
Languages
Python7%
SAS7%
Sign in to see how your skills match this stack Sign In
Full Forge Biologics tech stack 15 technologies · by team · pay by technology · changes · similar stacks

People

Timothy Miller
Executive Officer, Director
Chris Garabedian
Director
Molly McCartin
Director
Frederick Callori
Director
Molly Bonakdarpour
Director
Matthew Hammond
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
45/100
Stable
Open positions
13
3 opened / 4 closed in 30 days
Median time-to-fill
51 days
faster than 26% of the market
ATS activity
Every ~4 hours
11/02/2026
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Field & Service
20%
Analytics
16% ▲
Science & Research
16% ▼
Industrial Engineering
16% ▼
Management
8% ▲
Biotech
8% ▲
Activity Timeline
Added JMP to stack Oct 2026
Added CAPA to stack Oct 2026
Added Mandiant capa to stack Oct 2026
Added ITIL to stack Oct 2026
Added Microsoft Office to stack Sep 2026

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Columbus
Columbus United States
HQ
The Hearth - Columbus, OH
16 open roles 26 posted in 90 days 31% engineering 200-500 est. staff
hires for Analytics, Field & Service, Management
seen since Apr 2026 careers board, job postings

Jobs

≈ $66k – $124k per year (Estimated) · In office · Full-Time · 3+ years exp · Bachelor's Degree · Columbus
ITIL
Life Sciences
GMP
LIMS
Veeva
Apply
≈ $58k – $108k per year (Estimated) · In office · Full-Time · 5+ years exp · Bachelor's Degree · Columbus
GMP
MedTech
CAPA
Apply
≈ $57k – $106k per year (Estimated) · In office · Full-Time · Bachelor's Degree · Columbus
GMP
Veeva
MedTech
CAPA
Apply
≈ $36k – $80k per year (Estimated) · In office · Full-Time · Associate's Degree · Columbus
Chromatography
Bioreactors
GMP
Apply
≈ $80k – $152k per year (Estimated) · In office · Full-Time · 7+ years exp · Bachelor's Degree · Columbus
AutoCAD
SpaceTech
FMEA
Life Sciences
GMP
Apply
≈ $60k – $127k per year (Estimated) · In office · Full-Time · 2+ years exp · High School Diploma · Columbus
Cell Culture
Bioreactors
GMP
Apply
≈ $54k – $97k per year (Estimated) · In office · Full-Time · 2+ years exp · Bachelor's Degree · Columbus
GMP
Apply
≈ $44k – $78k per year (Estimated) · In office · Full-Time · 3+ years exp · Bachelor's Degree · Columbus
GMP
Apply
≈ $35k – $62k per year (Estimated) · In office · Full-Time · High School Diploma · Columbus
GMP
Apply
≈ $59k – $125k per year (Estimated) · In office · Full-Time · Bachelor's Degree · Columbus
Chromatography
GMP
Apply
≈ $50k – $104k per year (Estimated) · In office · Full-Time · Bachelor's Degree · Columbus
qPCR
ELISA
GMP
LIMS
MedTech
CAPA
Apply

Financials

Total raised
$160M
Latest round
Series B
Funding rounds
2
Funding rounds
Round Announced Amount
Series B 2021 $120M Details
Venture - Series Unknown 2020 $40M Details